Key takeaways
- Twelve checkable questions separate legitimate telehealth from a prescription mill, and every one of them can be answered before you pay.
- Bloodwork before treatment is the single most informative requirement, because the symptoms of low testosterone overlap almost completely with sleep apnoea, thyroid dysfunction, depression and iron deficiency.
- A clinic that will prescribe hormones from a symptom questionnaire alone is not practising medicine.
- The prescriber should be named and licensed in your state, reachable between visits, and someone should interpret your results rather than forward them.
- A written follow-up schedule that exists before you ask for it, and is included rather than sold as an upsell, is what separates ongoing care from a subscription.
Telehealth removed a real barrier. It also removed a real filter. The same technology that lets a physician review your labs and see you on video from four states away lets someone else take a card number, run a questionnaire, and ship a vial. Both are legally telehealth. From the outside they can look almost identical, because both have a clean website, a smiling doctor in a stock photo and a two-minute intake. The difference shows up in a specific set of details, and every one of them can be checked before you pay anything.
Before anything is prescribed
1. Is bloodwork required first? This is the single most informative question, and it is non-negotiable for testosterone therapy, hormone therapy for women, and peptides. A clinic that will prescribe hormones from a symptom questionnaire alone is not practising medicine. Comprehensive labs at intake are the standard, and the guidelines say so explicitly (Bhasin et al., J Clin Endocrinol Metab 2018). The reason is not bureaucratic: symptoms of low testosterone overlap almost completely with those of sleep apnoea, depression, thyroid dysfunction and iron deficiency, and treating the wrong one costs a year. Why you need bloodwork first covers the overlap.
2. Are the right tests being run? Requiring labs is necessary but not sufficient — the panel has to be adequate. For men starting testosterone therapy: total and free testosterone, SHBG, LH and FSH, a sensitive estradiol assay, full thyroid, haematocrit, lipids, PSA and a metabolic panel. The standard estradiol immunoassay is designed for female concentrations and performs poorly at male levels; using it to make decisions in men is a genuine quality signal (Ketha & Singh, Steroids 2015). For women: estradiol, progesterone, FSH, LH, thyroid, testosterone and DHEA-S, timed appropriately to the cycle where relevant. The blood panels guide covers what a complete panel contains.
3. Is there a real evaluation, or a form? Someone should be reading your history — medications, prior treatment, family history, sleep, alcohol, fertility plans. If nothing you enter could change the recommendation, it is not an evaluation.
4. Is there a documented reason you are being offered this specific treatment? A legitimate clinic can tell you which finding on your panel supports the recommendation. A mill offers whatever it sells to whoever arrives.
Who is actually treating you
5. Is the prescriber licensed in your state, and can you find them? A named clinician, verifiable against your state's licensing board. Nurse practitioners and physician assistants are entirely appropriate prescribers depending on state law and supervision arrangements — the question is whether the person is licensed where you are, not whether they hold a particular degree. Offshore prescribers are a hard stop.
6. Can you reach a clinician between appointments? Things come up: a side effect at week three, a lab result that needs explaining, a dose that does not feel right. Real clinics have secure messaging, scheduled video follow-ups, or both. A support ticket queue staffed by people who cannot answer clinical questions is not clinical access.
7. Who reviews your results, and do they explain them? Receiving a PDF of your labs is not interpretation. You should be told what changed, what it means and what happens next. If the only communication after a blood draw is a refill notification, nobody read it.
The monitoring schedule
8. Is there a written follow-up schedule, and does it exist before you ask? For testosterone therapy, at minimum month 3, month 6, then annually — haematocrit in particular needs watching, because erythrocytosis is the most common dose-limiting effect and it is silent until it is not (Basheer et al., Int Braz J Urol 2025; see also haematocrit management). For hormone therapy in women, 8-12 weeks after starting and then annually (The Menopause Society, Menopause 2022). For GLP-1 therapy, roughly every six months. A clinic that requires labs once, at intake, and never again is selling a subscription rather than providing care.
9. Is monitoring included, or billed as an upsell each time? This determines whether it actually happens. Monitoring priced as an optional extra is monitoring most patients will skip, and the clinic knows that.
The medication itself
10. Are the pharmacies named, US-based and appropriately registered? A US 503A or 503B compounding pharmacy, or a conventional pharmacy dispensing commercially manufactured product. Either is fine. Unnamed "partner pharmacies", overseas suppliers, or anything described as research-grade is not. You should be able to find out where your medication is made before it arrives.
11. Is the labelling patient-specific? Your name, the drug, the concentration, the prescriber, a lot number and a beyond-use date. Unlabelled vials, or labels naming no patient, indicate a supply chain that is not a prescription pathway.
12. Are protocols individualised? A clinic where every man receives the same weekly amount regardless of labs, body size, SHBG, haematocrit or fertility plans is not individualising anything. Individualisation is the entire clinical value on offer; without it you are paying a delivery fee.
The clinical pearl: the fastest screen is to look at where a clinic puts its detail. Legitimate practices publish the panel, the prescriber network, the pharmacies and the monitoring schedule on their main pages, because those are the things that justify the price. Mills lead with speed, discretion and the price, and the clinical detail is either buried or absent. Ten minutes on a website usually settles it.
The patterns that should stop you
- Prescribing without any bloodwork, or with a panel too narrow to interpret
- No named, state-licensed prescriber you can verify independently
- No follow-up labs after intake
- No way to reach a clinician with a clinical question
- Unnamed or offshore pharmacies; unlabelled product
- Identical protocols for everyone
- Marketing that promises a specific outcome, or a specific number on the scale
- Pressure to buy long prepaid blocks before any evaluation has happened
- No stated process for stopping, tapering, or being told treatment is not appropriate for you
That last one deserves a sentence of its own. A clinic that has never declined a patient is a clinic with no clinical threshold. Being told no is evidence the evaluation was real — why your doctor won't prescribe TRT covers the legitimate versions of that answer.
The patterns that should reassure you
Comprehensive labs required upfront and repeated on a schedule. A named prescriber licensed in your state. Named pharmacies. Results explained rather than forwarded. Someone reachable when something changes. Protocols that differ between patients because the labs differ. Educational content that describes mechanism and limitations rather than only benefits. And a clinic willing to tell you that a symptom probably has a different cause, and to investigate that instead.
Also worth noting: optimal and normal are not the same thing, and a good clinic can explain which framework it is using and why. That is a legitimate clinical debate rather than a red flag in itself — optimal versus normal lab ranges covers where the disagreement lies. What is a red flag is a clinic that cannot articulate its own position.
Bottom line
Legitimate telehealth and prescription mills are different products sold through the same interface, and twelve questions separate them: labs required, labs adequate, real evaluation, documented rationale, verifiable state-licensed prescriber, clinical access between visits, results actually interpreted, a written monitoring schedule, monitoring included rather than upsold, named US pharmacies, patient-specific labelling, and individualised protocols. Reputable clinics answer most or all of them on their public pages, because those answers are the reason to choose them. Mills answer few, and bury the rest. The check costs ten minutes, and it is the highest-return ten minutes in the entire process — is telehealth TRT legitimate covers the wider question of when this model is appropriate at all.
Educational content, not medical advice. Laboratory interpretation and any treatment decision are made by a licensed physician after individual evaluation. Individual results vary.
